Ceruloplasmin Is a Novel Adipokine Which Is Overexpressed in Adipose Tissue of Obese Subjects and in Obesity-Associated Cancer Cells

Erik Arner; Alistair R. R. Forrest; Anna Ehrlund; Niklas Mejhert; Masayoshi Itoh; Hideya Kawaji; Timo Lassmann; Jurga Laurencikiene; Mikael Rydén; Peter Arner; and the FANTOM consortium

doi:10.1371/journal.pone.0080274

Loading metrics

Open Access

Peer-reviewed

Research Article

Ceruloplasmin Is a Novel Adipokine Which Is Overexpressed in Adipose Tissue of Obese Subjects and in Obesity-Associated Cancer Cells

Erik Arner ,

* E-mail: arner@gsc.riken.jp (EA); peter.arner@ki.se (PA)

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Huddinge, Sweden, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan
⨯
Alistair R. R. Forrest,

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan
⨯
Anna Ehrlund,

Affiliation Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Huddinge, Sweden
⨯
Niklas Mejhert,

Affiliation Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Huddinge, Sweden
⨯
Masayoshi Itoh,

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Saitama, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan
⨯
Hideya Kawaji,

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Saitama, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan
⨯
Timo Lassmann,

Affiliations RIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama, Kanagawa, Japan, RIKEN Omics Science Center, Yokohama, Kanagawa, Japan
⨯
Jurga Laurencikiene,

Affiliation Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Huddinge, Sweden
⨯
Mikael Rydén,

Affiliation Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Huddinge, Sweden
⨯
Peter Arner ,

* E-mail: arner@gsc.riken.jp (EA); peter.arner@ki.se (PA)

Affiliation Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Huddinge, Sweden
⨯
and the FANTOM consortium

¶Membership of the FANTOM consortium is provided in Table S1.
⨯

Ceruloplasmin Is a Novel Adipokine Which Is Overexpressed in Adipose Tissue of Obese Subjects and in Obesity-Associated Cancer Cells

Erik Arner,
Alistair R. R. Forrest,
Anna Ehrlund,
Niklas Mejhert,
Masayoshi Itoh,
Hideya Kawaji,
Timo Lassmann,
Jurga Laurencikiene,
Mikael Rydén,
Peter Arner

Published: March 27, 2014
https://doi.org/10.1371/journal.pone.0080274

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Obesity
Is the Subject Area "Obesity" applicable to this article?

Thanks for your feedback.
Adipose tissue
Is the Subject Area "Adipose tissue" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Thyroid carcinoma
Is the Subject Area "Thyroid carcinoma" applicable to this article?

Thanks for your feedback.
Adipokines
Is the Subject Area "Adipokines" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Adipocytes
Is the Subject Area "Adipocytes" applicable to this article?

Thanks for your feedback.
Secretion
Is the Subject Area "Secretion" applicable to this article?

Thanks for your feedback.